Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.

about

Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.

Item

http://www.wikidata.org/entity/Q47108259

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical Evaluation of Terap C ...... in Patients with Hepatitis C.

@en

Clinical Evaluation of Terap C ...... in Patients with Hepatitis C.

@nl

type

Item

label

Clinical Evaluation of Terap C ...... in Patients with Hepatitis C.

@en

Clinical Evaluation of Terap C ...... in Patients with Hepatitis C.

@nl

prefLabel

Clinical Evaluation of Terap C ...... in Patients with Hepatitis C.

@en

Clinical Evaluation of Terap C ...... in Patients with Hepatitis C.

@nl

P1476

Clinical Evaluation of Terap C ...... in Patients with Hepatitis C.

@en

P2093

Alvarez-Lajonchere Liz

http://www.w3.org/2001/XMLSchema#string

Arús Soler Enrique R

http://www.w3.org/2001/XMLSchema#string

Castellanos Fernandez Marlen

http://www.w3.org/2001/XMLSchema#string

Cinza Estevez Zurina

http://www.w3.org/2001/XMLSchema#string

Dorta Guridi Zaily

http://www.w3.org/2001/XMLSchema#string

Dueñas-Carrera Santiago

http://www.w3.org/2001/XMLSchema#string

Ferrer Bataille Elena

http://www.w3.org/2001/XMLSchema#string

González Fabián Lisset

http://www.w3.org/2001/XMLSchema#string

Lazo Del Vallín Sacha

http://www.w3.org/2001/XMLSchema#string

Martínez Donato Gillian

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Systemic manifestations of hepatitis C infection

Direct anti-HCV agents

The New Era of Interferon-Free Treatment of Chronic Hepatitis C

Natural history of hepatitis C

Hepatitis C virus and vaccine development

A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients

Neutralizing antibody response to hepatitis C virus

P304

20-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CURTHERES.2017.04.006

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29158855

http://www.w3.org/2001/XMLSchema#string

P932

5681293

http://www.w3.org/2001/XMLSchema#string